Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
acting out
ausagieren
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
responsibilities in preparation of the eu draft constitutional treaty as acting deputy permanent under-secretary
2003-2004 responsibilities in preparation of the eu draft constitutional treaty as acting deputy permanent under-secretary
responsibilities in preparation of new financial perspective as acting deputy permanent under-secretary (eu affairs)
2005-2006 responsibilities in preparation of new financial perspective as acting deputy permanent under-secretary (eu affairs)
each participant shall also participate in a target2 cug , as specified by the ssp-providing cbs acting as the swift service administrator for the ssp .
each participant shall also participate in a target2 cug , as specified by the ssp-providing cbs acting as the swift service administrator for the ssp .
upon request by a participant acting as a settlement bank , the ecb shall open one or more sub-accounts in target2-ecb to be used for dedicating liquidity .
upon request by a participant acting as a settlement bank , the ecb shall open one or more sub-accounts in target2-ecb to be used for dedicating liquidity .
(1) acting in small lag présentation de riitta bagge lors d’une miniséance plénière, dans le cadre du séminaire organisé en corse,
(1) arbeiten in kleinen lags – vor- und nachteile, vortrag von riita bagge in einer mini-plenarsitzung des in korsika veranstalteten seminars
(16) public loans must be regarded to benefit undertakings if they are decided upon in circumstances which would not be acceptable to a private investor acting under normal market-economy principles.
(16) public loans must be regarded to benefit undertakings if they are decided upon in circumstances which would not be acceptable to a private investor acting under normal market-economy principles.
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications: